• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活在丹麦的格陵兰人的鹰爪豆碱氧化多态性

Sparteine oxidation polymorphism in Greenlanders living in Denmark.

作者信息

Brøsen K

出版信息

Br J Clin Pharmacol. 1986 Oct;22(4):415-9. doi: 10.1111/j.1365-2125.1986.tb02911.x.

DOI:10.1111/j.1365-2125.1986.tb02911.x
PMID:3768256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1401149/
Abstract

Sparteine oxidation appeared to be polymorphic in 185 healthy Greenlanders living in Denmark. Six subjects (3.2%) were phenotyped as poor metabolizers (PM) and 179 subjects as extensive metabolizers (EM). The metabolic ratio (MR) between sparteine and 2- + 5-dehydrosparteine in a 12 h urine sample ranged from 0.06-3.12 in EM and from 30-480 in PM. The excretion of dehydrosparteines accounted for less than 2.2% of the dose in PM and ranged from 5.6%-63% in EM. The urinary recovery (% of dose) of sparteine, 2-dehydrosparteine and total sparteine + dehydrosparteines was lower in Greenlander EM than in Danish EM (Brøsen et al., 1985). Incomplete urine collection in a substantial proportion of the Greenlanders could explain these discrepancies.

摘要

对居住在丹麦的185名健康格陵兰人进行的研究显示,鹰爪豆碱氧化似乎具有多态性。6名受试者(3.2%)被表型鉴定为慢代谢者(PM),179名受试者为快代谢者(EM)。12小时尿液样本中鹰爪豆碱与2- + 5-脱氢鹰爪豆碱的代谢率(MR)在快代谢者中为0.06 - 3.12,在慢代谢者中为30 - 480。脱氢鹰爪豆碱的排泄量在慢代谢者中占剂量的比例不到2.2%,在快代谢者中为5.6% - 63%。格陵兰快代谢者中鹰爪豆碱、2-脱氢鹰爪豆碱以及鹰爪豆碱 + 脱氢鹰爪豆碱的总尿液回收率(剂量百分比)低于丹麦快代谢者(布罗森等人,1985年)。相当一部分格陵兰人尿液收集不完全可能解释了这些差异。

相似文献

1
Sparteine oxidation polymorphism in Greenlanders living in Denmark.生活在丹麦的格陵兰人的鹰爪豆碱氧化多态性
Br J Clin Pharmacol. 1986 Oct;22(4):415-9. doi: 10.1111/j.1365-2125.1986.tb02911.x.
2
Sparteine oxidation polymorphism in Denmark.丹麦的鹰爪豆碱氧化多态性
Acta Pharmacol Toxicol (Copenh). 1985 Nov;57(5):357-60. doi: 10.1111/j.1600-0773.1985.tb00058.x.
3
Sparteine oxidation polymorphism: a family study.鹰爪豆碱氧化多态性:一项家族研究。
Br J Clin Pharmacol. 1986 Jun;21(6):661-7. doi: 10.1111/j.1365-2125.1986.tb05231.x.
4
Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.
Br J Clin Pharmacol. 1989 May;27(5):620-5. doi: 10.1111/j.1365-2125.1989.tb03426.x.
5
Sparteine and mephenytoin oxidation: genetic polymorphisms in east and west Greenland.司巴丁和美芬妥英氧化:东西格陵兰岛的基因多态性
Clin Pharmacol Ther. 1991 Jun;49(6):624-31. doi: 10.1038/clpt.1991.79.
6
Evidence for altered catalytic properties of the cytochrome P-450 involved in sparteine oxidation in poor metabolizers.
Clin Pharmacol Ther. 1987 Mar;41(3):320-5. doi: 10.1038/clpt.1987.34.
7
The relationship between paroxetine and the sparteine oxidation polymorphism.
Clin Pharmacol Ther. 1992 Mar;51(3):278-87. doi: 10.1038/clpt.1992.23.
8
The genetic polymorphism of sparteine metabolism.司巴丁代谢的基因多态性
Xenobiotica. 1986 May;16(5):465-81. doi: 10.3109/00498258609050252.
9
[Genetic polymorphism in sparteine oxidation--occurrence in healthy volunteers in Slovakia].
Bratisl Lek Listy. 1997 Feb;98(2):86-90.
10
A sensitive capillary GC assay for the determination of sparteine oxidation products in microsomal fractions of human liver.
Life Sci. 1986 May 12;38(19):1775-82. doi: 10.1016/0024-3205(86)90128-1.

引用本文的文献

1
Pharmaceutical-Related Poisonings in Greenland.格陵兰岛与药物相关的中毒事件
Basic Clin Pharmacol Toxicol. 2025 Apr;136(4):e70016. doi: 10.1111/bcpt.70016.
2
Genetically determined sparteine oxidation polymorphism in a Polish population.
Eur J Clin Pharmacol. 1994;46(5):481-3. doi: 10.1007/BF00191917.
3
Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasma.
Eur J Clin Pharmacol. 1989;36(6):555-60. doi: 10.1007/BF00637735.
4
Evidence for the polymorphic oxidation of debrisoquine in the Thai population.泰国人群中异喹胍多态性氧化的证据。
Br J Clin Pharmacol. 1990 Feb;29(2):244-7. doi: 10.1111/j.1365-2125.1990.tb03627.x.
5
Ethnic differences in drug disposition and responsiveness.药物处置和反应性的种族差异。
Clin Pharmacokinet. 1991 May;20(5):350-73. doi: 10.2165/00003088-199120050-00002.

本文引用的文献

1
A comparison between the behavior of Eskimos and non-Eskimos to the administration of isoniazid.爱斯基摩人与非爱斯基摩人对异烟肼给药的行为比较。
Am Rev Respir Dis. 1960 Apr;81:588-94. doi: 10.1164/arrd.1960.81.4.588.
2
E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.去甲替林的E型和Z型10-羟基化作用:与异喹胍多态性羟基化作用的关系。
Clin Pharmacol Ther. 1981 Aug;30(2):189-93. doi: 10.1038/clpt.1981.147.
3
In vitro metabolism of sparteine by human liver: competitive inhibition by debrisoquine.人肝脏对司巴丁的体外代谢:地昔帕明的竞争性抑制作用。
Can J Physiol Pharmacol. 1982 Jan;60(1):102-5. doi: 10.1139/y82-017.
4
Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities.鹰爪豆碱和异喹胍的多态性氧化:相关药物遗传学实体。
Clin Pharmacol Ther. 1982 Feb;31(2):184-6. doi: 10.1038/clpt.1982.29.
5
Sparteine metabolism in Canadian Caucasians.
Clin Pharmacol Ther. 1982 Jan;31(1):23-9. doi: 10.1038/clpt.1982.4.
6
Comparative pharmacogenetics of sparteine and debrisoquine.鹰爪豆碱和异喹胍的比较药物遗传学
Clin Pharmacol Ther. 1983 Mar;33(3):394-9. doi: 10.1038/clpt.1983.51.
7
Ethnic differences in drug metabolism.药物代谢中的种族差异。
Clin Pharmacokinet. 1982 Sep-Oct;7(5):373-400. doi: 10.2165/00003088-198207050-00001.
8
The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.运用分析双峰分布的新方法对人司巴丁和异喹胍代谢的遗传控制。
J Med Genet. 1983 Oct;20(5):321-9. doi: 10.1136/jmg.20.5.321.
9
Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylation.
Clin Pharmacol Ther. 1983 Oct;34(4):516-20. doi: 10.1038/clpt.1983.207.
10
Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme.通过使用针对类似大鼠酶产生的抗体来鉴定参与异喹胍和其他药物氧化的人肝脏细胞色素P-450。
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7348-52. doi: 10.1073/pnas.81.23.7348.